They argued that these would only stifle innovation at pharmaceutical firms more stating that the inducement lies in R&D into drugs which will need large investments into R&D. Having a mutating virus, the produced nations felt that these kinds of selections wouldn't be helpful.  The generation of such specialised companies was a direct reaction